[HTML] mdpi.com

[HTML][HTML] Potential adverse drug events and drug–drug interactions with medical and consumer cannabidiol (CBD) use

JD Brown, AG Winterstein - Journal of clinical medicine, 2019 - mdpi.com
Cannabidiol (CBD) is ubiquitous in state-based medical cannabis programs and consumer
products for complementary health or recreational use. CBD has intrinsic pharmacologic …
被引用次数：303 相关文章
[PDF] semanticscholar.org

[PDF][PDF] Potential Adverse Drug Events and Drug–Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use

JD Brown, AG Winterstein - J. Clin. Med, 2019 - pdfs.semanticscholar.org
Cannabidiol (CBD) is ubiquitous in state-based medical cannabis programs and consumer
products for complementary health or recreational use. CBD has intrinsic pharmacologic …
[PDF] greenleafmc.ca

[PDF][PDF] Potential Adverse Drug Events and Drug–Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use

JD Brown, AG Winterstein - J. Clin. Med, 2019 - greenleafmc.ca
Cannabidiol (CBD) is ubiquitous in state-based medical cannabis programs and consumer
products for complementary health or recreational use. CBD has intrinsic pharmacologic …
[PDF] researchgate.net

[PDF][PDF] Potential Adverse Drug Events and Drug–Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use

JD Brown, AG Winterstein - J. Clin. Med, 2019 - researchgate.net
Cannabidiol (CBD) is ubiquitous in state-based medical cannabis programs and consumer
products for complementary health or recreational use. CBD has intrinsic pharmacologic …

Potential adverse drug events and drug-drug interactions with medical and consumer cannabidiol (CBD) use

JD Brown, AG Winterstein - Journal of clinical medicine, 2019 - safetylit.org
Cannabidiol (CBD) is ubiquitous in state-based medical cannabis programs and consumer
products for complementary health or recreational use. CBD has intrinsic pharmacologic …
[HTML] nih.gov

[HTML][HTML] Potential Adverse Drug Events and Drug–Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use

JD Brown, AG Winterstein - Journal of Clinical Medicine, 2019 - ncbi.nlm.nih.gov
Cannabidiol (CBD) is ubiquitous in state-based medical cannabis programs and consumer
products for complementary health or recreational use. CBD has intrinsic pharmacologic …

Potential Adverse Drug Events and Drug–Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use.

JD Brown, AG Winterstein - Journal of Clinical Medicine, 2019 - search.ebscohost.com
Cannabidiol (CBD) is ubiquitous in state-based medical cannabis programs and consumer
products for complementary health or recreational use. CBD has intrinsic pharmacologic …

Potential Adverse Drug Events and Drug-Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use

JD Brown, AG Winterstein - Journal of clinical medicine, 2019 - pubmed.ncbi.nlm.nih.gov
Cannabidiol (CBD) is ubiquitous in state-based medical cannabis programs and consumer
products for complementary health or recreational use. CBD has intrinsic pharmacologic …
[PDF] nopotshops.com

[PDF][PDF] Potential Adverse Drug Events and Drug–Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use

JD Brown, AG Winterstein - J. Clin. Med, 2019 - nopotshops.com
Cannabidiol (CBD) is ubiquitous in state-based medical cannabis programs and consumer
products for complementary health or recreational use. CBD has intrinsic pharmacologic …

Potential Adverse Drug Events and Drug-Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use.

JD Brown, AG Winterstein - Journal of Clinical Medicine, 2019 - europepmc.org
Cannabidiol (CBD) is ubiquitous in state-based medical cannabis programs and consumer
products for complementary health or recreational use. CBD has intrinsic pharmacologic …